Header Logo

SHARADA MOKKAPATI

TitleInstructor
InstitutionMD Anderson
DepartmentUrology
Address1515 Holcombe Blvd.
Houston TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Narayan VM, Tholomier C, Mokkapati S, Martini A, Caruso VM, Goudarzi M, Mazzarella BC, Phillips KG, Bicocca VT, Levin TG, Yla-Herttuala S, McConkey DJ, Dinney CPN. Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Gu?rin-unresponsive Non-muscle-invasive Bladder Cancer Treated with Nadofaragene Firadenovec. Eur Urol Oncol. 2024 Oct 14. PMID: 39406613.
      Citations:    Fields:    
    2. Steinmetz AR, Mokkapati S, McConkey D, Dinney CP. The Evolution of Nadofaragene Firadenovec: A Review and the Path Forward. Bladder Cancer. 2024; 10(2):105-112. PMID: 39131870; PMCID: PMC11308647.
      Citations: 1     
    3. Martini A, Tholomier C, Mokkapati S, Dinney CPN. Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval. Front Immunol. 2023; 14:1260498. PMID: 37705979; PMCID: PMC10495564.
      Citations: 3     Fields:    Translation:Humans
    4. Tholomier C, Martini A, Mokkapati S, Dinney CP. The current status of gene therapy in bladder cancer. Expert Rev Anticancer Ther. 2023 05; 23(5):531-543. PMID: 37055873.
      Citations: 1     Fields:    Translation:Humans
    5. Mokkapati S, Narayan VM, Manyam GC, Lim AH, Duplisea JJ, Kokorovic A, Miest TS, Mitra AP, Plote D, Anand SS, Metcalfe MJ, Dunner K, Johnson BA, Czerniak BA, Nieminen T, Heikura T, Yla-Herttuala S, Parker NR, Schluns KS, McConkey DJ, Dinney CP. Lentiviral interferon: A novel method for gene therapy in bladder cancer. Mol Ther Oncolytics. 2022 Sep 15; 26:141-157. PMID: 35847448; PMCID: PMC9251210.
      Citations:    
    6. Mitra AP, Narayan VM, Mokkapati S, Miest T, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown GA, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL, Sankin AI, Boyd A, O'Donnell MA, Philipson R, Sawutz D, Parker NR, McConkey DJ, Dinney CPN, Yl?-Herttuala S. Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial. Eur Urol. 2022 03; 81(3):223-228. PMID: 34933753; PMCID: PMC8891058.
      Citations:    Fields:    Translation:Humans
    7. Mokkapati S, Porten SP, Narayan VM, Lim AH, Jayaratna IS, Roth B, Cheng T, Navai N, Wszolek M, Melquist J, Manyam G, Choi W, Broom B, Pretzsch S, Czerniak B, McConkey DJ, Dinney CPN. TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer. Mol Cancer Res. 2020 06; 18(6):811-821. PMID: 32122956.
      Citations:    Fields:    Translation:HumansAnimalsCells
    8. Nunez L, Mokkapati S, Yu C, Deng JM, Behringer RR, Matin A. Generation of a novel mouse strain with conditional, cell-type specific, expression of DND1. Genesis. 2019 11; 57(11-12):e23335. PMID: 31513344.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    9. Plote D, Choi W, Mokkapati S, Sundi D, Ferguson JE, Duplisea J, Parker NR, Yla-Herttuala S, Committee SCB, McConkey D, Schluns KS, Dinney CP. Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation. Oncoimmunology. 2019; 8(5):e1577125. PMID: 31069136; PMCID: PMC6493227.
      Citations: 4     Fields:    
    10. Duplisea JJ, Mokkapati S, Plote D, Schluns KS, McConkey DJ, Yla-Herttuala S, Parker NR, Dinney CP. The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside. World J Urol. 2019 Oct; 37(10):2041-2049. PMID: 30415317; PMCID: PMC6511323.
      Citations: 6     Fields:    Translation:Humans
    11. Li R, Metcalfe MJ, Ferguson JE, Mokkapati S, Dinney CP, Navai N, McConkey DJ, Sahai SK, Kamat AM, Nogueras Gonz?lez GM. Effects of thiazolidinedione in patients with active bladder cancer. BJU Int. 2018 02; 121(2):244-251. PMID: 28872778; PMCID: PMC5780258.
      Citations: 3     Fields:    Translation:Humans
    12. Jinesh GG, Mokkapati S, Zhu K, Morales EE. Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacks. Apoptosis. 2016 11; 21(11):1203-1213. PMID: 27651368.
      Citations: 20     Fields:    Translation:HumansAnimals
    13. Huang L, Mokkapati S, Hu Q, Ruteshouser EC, Hicks MJ, Huff V. Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with ?-Catenin Activation or Wt1 Ablation and Igf2 Upregulation. Neoplasia. 2016 Feb; 18(2):71-81. PMID: 26936393; PMCID: PMC5005262.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    14. Mokkapati S, Niopek K, Huang L, Cunniff KJ, Ruteshouser EC, deCaestecker M, Finegold MJ, Huff V. ?-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma. Cancer Res. 2014 Aug 15; 74(16):4515-25. PMID: 24848510; PMCID: PMC4134699.
      Citations: 41     Fields:    Translation:AnimalsCells
    15. John S, Thiebach L, Frie C, Mokkapati S, Bechtel M, Nischt R, Rosser-Davies S, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is required for proper hair development, but not the formation of the epidermal barrier. PLoS One. 2012; 7(4):e34252. PMID: 22496784; PMCID: PMC3319564.
      Citations: 20     Fields:    Translation:AnimalsCells
    16. Mokkapati S, Bechtel M, Reibetanz M, Miosge N, Nischt R. Absence of the basement membrane component nidogen 2, but not of nidogen 1, results in increased lung metastasis in mice. J Histochem Cytochem. 2012 Apr; 60(4):280-9. PMID: 22260998; PMCID: PMC3351237.
      Citations: 12     Fields:    Translation:AnimalsCells
    17. Mokkapati S, Fleger-Weckmann A, Bechtel M, Koch M, Breitkreutz D, Mayer U, Smyth N, Nischt R. Basement membrane deposition of nidogen 1 but not nidogen 2 requires the nidogen binding module of the laminin gamma1 chain. J Biol Chem. 2011 Jan 21; 286(3):1911-8. PMID: 21084308; PMCID: PMC3023487.
      Citations: 7     Fields:    Translation:Animals
    18. Baranowsky A, Mokkapati S, Bechtel M, Miosge N, Wickenhauser C, Smyth N, Nischt R, Kr?gel J. Impaired wound healing in mice lacking the basement membrane protein nidogen 1. Matrix Biol. 2010 Jan; 29(1):15-21. PMID: 19766719.
      Citations: 13     Fields:    Translation:AnimalsCells
    19. Ho MS, Mokkapati S, Nischt R, Smyth N, B?se K. Nidogens-Extracellular matrix linker molecules. Microsc Res Tech. 2008 May; 71(5):387-95. PMID: 18219668.
      Citations: 49     Fields:    Translation:HumansAnimalsCells
    20. Mokkapati S, Baranowsky A, Mirancea N, Smyth N, Breitkreutz D, Nischt R. Basement membranes in skin are differently affected by lack of nidogen 1 and 2. J Invest Dermatol. 2008 Sep; 128(9):2259-67. PMID: 18356808.
      Citations: 20     Fields:    Translation:AnimalsCells
    21. Nischt R, Schmidt C, Mirancea N, Baranowsky A, Mokkapati S, Smyth N, Woenne EC, Boukamp P, Breitkreutz D, Stark HJ. Lack of nidogen-1 and -2 prevents basement membrane assembly in skin-organotypic coculture. J Invest Dermatol. 2007 Mar; 127(3):545-54. PMID: 17008882.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    22. Bader BL, Smyth N, Nedbal S, Miosge N, Baranowsky A, Mokkapati S, Murshed M, Nischt R. Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice. Mol Cell Biol. 2005 Aug; 25(15):6846-56. PMID: 16024816; PMCID: PMC1190363.
      Citations: 82     Fields:    Translation:Animals
    23. Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation. Neoplasia (United States). 18:71-81.
    24. Pim kinase isoforms. Apoptosis. 21:1203-1213.
    MOKKAPATI's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (114)
    Explore
    _
    Co-Authors (13)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _